Drug Trial Radar · NCT05981846
A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
279
Actual
Start
Sep 4, 2023
Primary completion
Nov 3, 2023
Study completion Nov 3, 2023
Sponsor
- Lead sponsor
- Hipra Scientific, S.L.UIndustry
- Sponsor type
- Industry
- First posted
- Aug 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase II, randomized, double-blind, multi-centre trial to evaluate the safety and immunogenicity of BIMERVAX® when coadministered with seasonal surface antigen inactivated adjuvanted influenza vaccine (SIIV) in adults older than 65 years of age fully vaccinated against COVID-19.
Conditions
- SARS CoV 2 Infection
- Influenza, Human
Interventions
BIMERVAXBiological
One dose of booster vaccine
SIIVBiological
One dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number, percentage, and characteristics of solicited local and systemic reactions through Day 7 after vaccination.Time frame: Day 0, Day 7
- Number, percentage, and characteristics of unsolicited local and systemic adverse events (AEs) through the end of the study.Time frame: Day 0, Day 7, Day 28
- Number and percentage of serious adverse events (SAEs) through the end of the study.Time frame: Day 0, Day 7, Day 28
- Number and percentage of adverse events of special interest (AESI) through the end of the studyTime frame: Day 0, Day 7, Day 28
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Hospital HM Modelo
A Coruña, A Coruña, Spain
Hospital Clínico Universitario de Santiago
Santiago de Compostela, A Coruña, Spain
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital Clínic de Barcelona
Barcelona, Barcelona, Spain
CAP Centelles
Centelles, Barcelona, Spain
Hospital Josep Trueta
Girona, Girona, Spain
Hospital Regional de Málaga
Málaga, Málaga, Spain
Hospital Clínico de Valladolid
Valladolid, Valladolid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.